Evidence map›Paper›PMID 41096286›Full record

ArticlePolymers2025

Multifunctional Polymer-Modified P-CaO

Yanle Zhi, Shengchao Wang, Haibo Zhang, Guimin Xue, Zhiqiang Zhang

Abstract read
In one paragraph

Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yanle ZhiAcademy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou 450045, China.ORCID 0000-0001-6066-2231
Shengchao WangAcademy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou 450045, China.
Haibo ZhangAcademy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou 450045, China.ORCID 0000-0003-3082-8012
Guimin XueCollaborative Innovation Center of Research and Development on the Whole Industry Chain of Yu-Yao, Henan University of Chinese Medicine, Zhengzhou 450046, China.
Zhiqiang ZhangAcademy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou 450045, China.ORCID 0000-0002-7729-1104

Funding

Collaborative Innovation Center of Research and Development on the Whole Industry Chain of Yu-Yao 2024YYXT-KFKT-07Program for Innovative Research Team (in Science and Technology) in University of Henan Province 24IRTSTHN039
6 · The paper itself

Abstract

The success of mRNA-based SARS-CoV-2 vaccines has been confirmed in both preclinical and clinical settings. However, the development of safe and efficient mRNA vaccine delivery platforms remains challenging. In this report, PBAE-G-B-SS-modified CaO

Indexed as

dendrobium huoshanense polysaccharideimmune evaluationnanoparticlesvaccine adjuvant

Identifiers

PMID41096286
PMCPMC12526564

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.